Unknown PHASE4 INTERVENTIONAL 1-arm NCT02871466

Stem Cells Therapy in Advanced Heart Failure

Intra Cardiac Autologous Stem Cells Infusion May Improve Clinical Outcomes in Failing Heart Subjects Refractory to Maximal Drug Therapy and Internal Cardioverter With a Defibrillator (ICD) Recipients

Sponsor: University of Campania Luigi Vanvitelli

Conditions Congestive Heart Failure

Interventions stem cells infusion

Updated 8 times since 2017 Last updated: Aug 11, 2020 Started: Jan 31, 2010 Primary completion: Jan 31, 2022 Completion: Jul 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Congestive Heart Failure, this trial is ongoing. The trial is conducted by University of Campania Luigi Vanvitelli and has accumulated 8 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Recruiting PHASE4
Sep 2020 — Jan 2021 [monthly]

Recruiting PHASE4

Status: Completed → Recruiting

▶ Show 3 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed PHASE4
Sep 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Sep 2017 [monthly]

Completed PHASE4

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Campania Luigi Vanvitelli

Data source: University of Campania Luigi Vanvitelli

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Naples, Italy
• Napoli, Italy